{"AllianceGenome": "4585", "HGNC": "4585", "MIM": "138253", "_id": "2903", "_version": 2, "accession": {"genomic": ["AC006531.1", "AC007218.6", "AC022168.6", "AC026423.9", "AC133565.5", "AH012185.2", "CH471112.2", "CP068262.2", "KF456168.1", "MW415422.1", "NC_000016.10", "NC_060940.1", "NG_011812.2"], "protein": ["AAB49992.1", "AAB60343.1", "AAI17132.1", "AAI43274.1", "BAD92932.1", "BAG58499.1", "EAW85187.1", "NP_000824.1", "NP_001127879.1", "NP_001127880.1", "Q12879.1", "QRI93602.1", "XP_016878661.1", "XP_016878662.1", "XP_047289949.1", "XP_047289950.1", "XP_054236123.1", "XP_054236124.1", "XP_054236125.1", "XP_054236126.1"], "rna": ["AB209695.1", "AK124698.1", "AK295620.1", "AK308862.1", "BC117131.1", "BC143273.1", "CR749843.1", "NM_000833.5", "NM_001134407.3", "NM_001134408.2", "R43097.1", "U07199.1", "U09002.1", "U90277.1", "XM_017023172.2", "XM_017023173.2", "XM_047433993.1", "XM_047433994.1", "XM_054380148.1", "XM_054380149.1", "XM_054380150.1", "XM_054380151.1"], "translation": [{"protein": "XP_054236125.1", "rna": "XM_054380150.1"}, {"protein": "XP_054236126.1", "rna": "XM_054380151.1"}, {"protein": "XP_054236123.1", "rna": "XM_054380148.1"}, {"protein": "AAI17132.1", "rna": "BC117131.1"}, {"protein": "AAB49992.1", "rna": "U90277.1"}, {"protein": "AAB60343.1", "rna": "U09002.1"}, {"protein": "XP_016878661.1", "rna": "XM_017023172.2"}, {"protein": "XP_054236124.1", "rna": "XM_054380149.1"}, {"protein": "NP_001127880.1", "rna": "NM_001134408.2"}, {"protein": "AAI43274.1", "rna": "BC143273.1"}, {"protein": "XP_047289949.1", "rna": "XM_047433993.1"}, {"protein": "BAD92932.1", "rna": "AB209695.1"}, {"protein": "XP_016878662.1", "rna": "XM_017023173.2"}, {"protein": "XP_047289950.1", "rna": "XM_047433994.1"}, {"protein": "BAG58499.1", "rna": "AK295620.1"}, {"protein": "NP_001127879.1", "rna": "NM_001134407.3"}, {"protein": "NP_000824.1", "rna": "NM_000833.5"}]}, "alias": ["EPND", "FESD", "GluN2A", "LKS", "NMDAR2A", "NR2A"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2019-07-16T16:00:00.000Z", "disease_label": "complex neurodevelopmental disorder", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0100038", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_0c405372-b99b-42fc-836d-65d7c0cbd279-2019-07-16T160000.000Z", "sop": "SOP6"}}, "ensembl": {"gene": "ENSG00000183454", "protein": ["ENSP00000332549", "ENSP00000379818", "ENSP00000441572", "ENSP00000454998", "ENSP00000489946", "ENSP00000490232", "ENSP00000490676", "ENSP00000502200", "ENSP00000502752"], "transcript": ["ENST00000330684", "ENST00000396573", "ENST00000461292", "ENST00000463531", "ENST00000535259", "ENST00000562109", "ENST00000566665", "ENST00000566670", "ENST00000566683", "ENST00000568247", "ENST00000636273", "ENST00000636406", "ENST00000637188", "ENST00000637334", "ENST00000637393", "ENST00000674742", "ENST00000675189", "ENST00000675398", "ENST00000676032"], "translation": [{"protein": "ENSP00000379818", "rna": "ENST00000396573"}, {"protein": "ENSP00000332549", "rna": "ENST00000330684"}, {"protein": "ENSP00000441572", "rna": "ENST00000535259"}, {"protein": "ENSP00000502200", "rna": "ENST00000674742"}, {"protein": "ENSP00000502752", "rna": "ENST00000675398"}, {"protein": "ENSP00000454998", "rna": "ENST00000562109"}, {"protein": "ENSP00000490232", "rna": "ENST00000637393"}, {"protein": "ENSP00000490676", "rna": "ENST00000636406"}, {"protein": "ENSP00000489946", "rna": "ENST00000637188"}], "type_of_gene": "protein_coding"}, "entrezgene": "2903", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 31.1721865, "exp_mis": 565.9620694, "exp_syn": 278.818497, "lof_z": 4.9983498877316, "mis_z": 3.80281784083673, "mu_lof": 2.30737411687e-06, "mu_mis": 4.95077306265e-05, "mu_syn": 2.41645459661e-05, "n_lof": 3.0, "n_mis": 381.0, "n_syn": 283.0, "p_li": 0.99804480805101, "p_null": 4.49472318599573e-10, "p_rec": 0.00195519149951803, "syn_z": -0.155246125569693}, "bp": 4395, "cds_end": 10274268, "cds_start": 9857005, "n_exons": 12, "nonpsych": {"exp_lof": 27.9662102, "exp_mis": 512.0026758, "exp_syn": 252.110022, "lof_z": 4.82218348909474, "mis_z": 4.14614802570498, "mu_lof": 2.30737411687e-06, "mu_mis": 4.95077306265e-05, "mu_syn": 2.41645459661e-05, "n_lof": 2.0, "n_mis": 326.0, "n_syn": 250.0, "p_li": 0.998910618505245, "p_null": 6.50911378285049e-10, "p_rec": 0.00108938084384376, "syn_z": 0.0836663796724154}, "nontcga": {"exp_lof": 28.65427581, "exp_mis": 520.6610057, "exp_syn": 256.48889511, "lof_z": 4.72766110453283, "mis_z": 3.81353940591168, "mu_lof": 2.30737411687e-06, "mu_mis": 4.95077306265e-05, "mu_syn": 2.41645459661e-05, "n_lof": 3.0, "n_mis": 346.0, "n_syn": 266.0, "p_li": 0.995200189231648, "p_null": 4.01483840670369e-09, "p_rec": 0.00479980675351333, "syn_z": -0.376026756318571}, "transcript": "ENST00000396573.2"}, "exons": [{"cdsend": 10180411, "cdsstart": 9763148, "chr": "16", "position": [[9753407, 9764948], [9768850, 9769089], [9798276, 9798464], [9822263, 9822424], [9829422, 9829652], [9834104, 9834230], [9840646, 9840800], [9840935, 9841104], [9849755, 9849961], [9890985, 9891100], [9937958, 9938551], [10179997, 10180429], [10181876, 10182067], [10182653, 10182908]], "strand": -1, "transcript": "NM_000833", "txend": 10182908, "txstart": 9753407}, {"cdsend": 10180411, "cdsstart": 9763148, "chr": "16", "position": [[9753407, 9764948], [9768850, 9769089], [9798276, 9798464], [9822263, 9822424], [9829422, 9829652], [9834104, 9834230], [9840646, 9840800], [9840935, 9841104], [9849755, 9849961], [9890985, 9891100], [9937958, 9938551], [10179997, 10180429], [10181876, 10182428]], "strand": -1, "transcript": "NM_001134407", "txend": 10182428, "txstart": 9753407}, {"cdsend": 10180411, "cdsstart": 9763354, "chr": "16", "position": [[9753404, 9763428], [9763771, 9764948], [9768850, 9769089], [9798276, 9798464], [9822263, 9822424], [9829422, 9829652], [9834104, 9834230], [9840646, 9840800], [9840935, 9841104], [9849755, 9849961], [9890985, 9891100], [9937958, 9938551], [10179997, 10180429], [10181876, 10182067]], "strand": -1, "transcript": "NM_001134408", "txend": 10182067, "txstart": 9753404}], "exons_hg19": [{"cdsend": 10274268, "cdsstart": 9857005, "chr": "16", "position": [[9847264, 9858805], [9862707, 9862946], [9892133, 9892321], [9916120, 9916281], [9923279, 9923509], [9927961, 9928087], [9934503, 9934657], [9934792, 9934961], [9943612, 9943818], [9984842, 9984957], [10031815, 10032408], [10273854, 10274286], [10275733, 10275924], [10276510, 10276765]], "strand": -1, "transcript": "NM_000833", "txend": 10276765, "txstart": 9847264}, {"cdsend": 10274268, "cdsstart": 9857005, "chr": "16", "position": [[9847264, 9858805], [9862707, 9862946], [9892133, 9892321], [9916120, 9916281], [9923279, 9923509], [9927961, 9928087], [9934503, 9934657], [9934792, 9934961], [9943612, 9943818], [9984842, 9984957], [10031815, 10032408], [10273854, 10274286], [10275733, 10276285]], "strand": -1, "transcript": "NM_001134407", "txend": 10276285, "txstart": 9847264}, {"cdsend": 10274268, "cdsstart": 9857211, "chr": "16", "position": [[9847261, 9857285], [9857628, 9858805], [9862707, 9862946], [9892133, 9892321], [9916120, 9916281], [9923279, 9923509], [9927961, 9928087], [9934503, 9934657], [9934792, 9934961], [9943612, 9943818], [9984842, 9984957], [10031815, 10032408], [10273854, 10274286], [10275733, 10275924]], "strand": -1, "transcript": "NM_001134408", "txend": 10275924, "txstart": 9847261}], "generif": [{"pubmed": 11985816, "text": "The C-terminus of NR2A is critical for modulation of desensitization by calcineurin."}, {"pubmed": 12082569, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12127670, "text": "The levels of NR2A mRNA are decreased in Alzheimer disease hippocampus and entorhinal cortex compared to controls."}, {"pubmed": 12724619, "text": "In schizophrenia, analysis of the GRIN2A gene detected four single nucleotide polymorphisms, and a variable (GT)(n) repeat in the promoter region."}, {"pubmed": 12724619, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12893641, "text": "human cerebral endothelial cells express the message and protein for NMDA receptors."}, {"pubmed": 12956718, "text": "N-methyl-d-aspartate receptor subunit messenger ribonucleic acids are differentially expressed during postnatal development of the human hippocampus"}, {"pubmed": 14699423, "text": "Owing to its role in aspects of cognition, linkage of 4 GRIN2A polymorphisms was studied in inhibitory control, verbal short-term memory and verbal working memory. There was no significant evidence of linkage between GRIN2A and these phenotypes."}, {"pubmed": 14732708, "text": "disulfide bridging and structural integrity within the NR1 N-terminal domain is requisite for cell surface N-methyl-D-aspartate receptor expression"}, {"pubmed": 14966475, "text": "genetic variation in GRIN2A may confer increased risk for attention deficit disorder with hyperactivity"}, {"pubmed": 15742215, "text": "NR2A subtypes mainly expressed in the striatum, may influence the variability in age of onset of Huntington disease."}, {"pubmed": 15742215, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15774266, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15774266, "text": "a probable genetic effect for the GRIN2A promoter (GT)n variation on the predisposition to schizophrenia in Japanese cohorts."}, {"pubmed": 15830322, "text": "Analysis of the autistic disorder susceptibility locus suggests an association on chromosome 16p between GRIN2A and ABAT."}, {"pubmed": 15888440, "text": "the conformation of NR1 subunit homodimers is affected by the partner NR2 subunits during the formation of heteromeric receptor complexes"}, {"pubmed": 16266783, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16476413, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17011703, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17018562, "text": "GRIN2A and TCERG1 may show true association with residual age of onset for Huntington's disease in genetic association tests in 443 affected people from a large set of kindreds from Venezuela."}, {"pubmed": 17105731, "text": "analysis of the role of the glutamate binding pocket in agonist affinity and efficacy of N-methyl-D-aspartate receptor activation"}, {"pubmed": 17255096, "text": "the three amino acid tail following the TM4 region of the N-methyl-D-aspartate receptor (NR) 2 subunits is sufficient to overcome endoplasmic reticulum retention of NR1-1a subunit"}, {"pubmed": 17433503, "text": "Our observations suggest a novel mechanism whereby subunit specific changes in the NMDA receptor complex may be linked to chronic anxiety in AD via effects on GlyRS function."}, {"pubmed": 17519952, "text": "NR2A(F637) influences NMDA receptor affinity, ion channel gating, and ethanol sensitivity; the changes in NMDA receptor affinity are likely to be the result of altered ion channel gating"}, {"pubmed": 17569088, "text": "NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner."}, {"pubmed": 17569088, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 17922030, "text": "NMDAR2A is commonly hypermethylated in primary human colorectal carcinoma and possesses tumor-suppressive activity."}, {"pubmed": 17942280, "text": "laser capture microdissection combined with quantitative PCR was used to examine the expression of AMPA (GRIA1-4) and NMDA (GRIN1, 2A and 2B) subunit mRNA levels in Layer II/III and Layer V pyramidal cells in the DLPFC."}, {"pubmed": 18178157, "text": "The results of the present study, thus, suggest that blockage of NMDA receptors including the NR2A subunit suppresses MKN45 cell proliferation due to cell cycle arrest at the G(1) phase."}, {"pubmed": 18570704, "text": "This study found that the NR2A protein level significationalty elevated in pateint with deression."}, {"pubmed": 18606955, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18990687, "text": "NR1-1a (D732E)/NR2A and NR1-1a (D723A)/NR2A trafficked as efficiently as NR1-1a/NR2A, there was a 90% decrease in surface expression for NR1-1a (D732A)/NR2A."}, {"pubmed": 18991843, "text": "Data show that expression of NMDA receptor NR1, NR2A, and NR2B subunits is significantly lower in brains of cirrhotic alcoholics than in the corresponding areas in both controls and alcoholics without co-morbid disease."}, {"pubmed": 19058789, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19086053, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19088076, "text": "SGK1 phosphorylation of IkappaB Kinase alpha and p300 Up-regulates NF-kappaB activity and increases N-Methyl-D-aspartate receptor NR2A and NR2B expression."}, {"pubmed": 19156168, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19268276, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19352218, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19834457, "text": "Tyrosine-1325 phosphorylation regulates N-methyl-D-aspartate (NMDA) receptor channel properties and NMDA receptor-mediated downstream signaling to modulate depression-related behavior."}, {"pubmed": 19874574, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20070378, "text": "Functional (GT)n polymorphisms in promoter region of N-methyl-d-aspartate receptor 2A subunit (GRIN2A) gene affect hippocampal and amygdala volumes"}, {"pubmed": 20070378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20148871, "text": "the PFC, glutamatergic regulation of PV-containing inhibitory neurons via NR2A-containing NMDA receptors does not appear to be altered in bipolar disorder."}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20398908, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20448061, "text": "Data demonstrate that tat treatment of human neurons results in tyrosine phosphorylation of the NMDAR subunit 2A (NR2A) in a src kinase-dependent manner."}, {"pubmed": 20468064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20677014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20848605, "text": "NMDA subunit NR2A is not involved in amygdala hyperexcitability of patients with temporal lobe epilepsy."}, {"pubmed": 20890276, "text": "Mutations cause mental neurodevvelopmental disordes such as epilepsy and mental retardation."}, {"pubmed": 21152063, "text": "Data show that that all seven currently known NMDAR subunits (NR1, NR2A, NR2B, NR2C, NR2D, NR3A and NR3B) are expressed in astrocytes, but at different levels."}, {"pubmed": 21371516, "text": "This review focuses on the role of the NMDA receptor subunits in schizophrenia, particularly via altering the balance of NR2 subunits during early development, could influence NRG1 signalling {REVIEW}"}, {"pubmed": 21499247, "text": "Exome sequencing identifies GRIN2A as frequently mutated in melanoma."}, {"pubmed": 21499247, "text": "In melanoma, GRIN2A is identified as a common somatic mutation."}, {"pubmed": 21507155, "text": "The results show a significant association between polymorphism of the GRIN2A gene and alcoholism."}, {"pubmed": 21876681, "text": "glutamate receptor gene GRIN2A is a Parkinson's disease modifier gene via interaction with coffee"}, {"pubmed": 21883175, "text": "identified as prime candidate gene for photoparoxysmal response"}, {"pubmed": 22004137, "text": "Polymorphism rs11866328 in the GRIN2A gene might be a genetic variant underlying the susceptibility of HBV carriers to disease progression."}, {"pubmed": 22486492, "text": "After 7 days of chronic alcohol exposure there are significant increases in mRNA expression of GRIN2A in cultured neurons derived from alcoholic subjects, but not in cultures from nonalcoholics."}, {"pubmed": 22833210, "text": "Two de novo mutations in GRIN2A are identified in patients with sporadic schizophrenia."}, {"pubmed": 22851457, "text": "GRIN2A single nucleotide polymorphisms are asociated with phenotypic brain volume variations in multiple slcerosis."}, {"pubmed": 23271275, "text": "B7T inhibition of NMDA current mediated by NR1/NR2B receptor."}, {"pubmed": 23693003, "text": "The results of this study indicated that rs2072450 of GRIN2A might confer risk for alcohol dependence through deficient fear acquisition indexed by a diminished amygdala response during aversive learning,."}, {"pubmed": 23847085, "text": "GluN2A(F636) plays an important role in both channel function and ethanol inhibition in NMDA receptors."}, {"pubmed": 23933818, "text": "GRIN2A mutations cause epilepsy-aphasia spectrum disorders."}, {"pubmed": 23933819, "text": "Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes."}, {"pubmed": 23940648, "text": "A possible role for GRIN2A polymorphisms in heroin addiction."}, {"pubmed": 24125812, "text": "study describes two children with a GRIN2A mutation and epilepsy, with one having a microdeletion on chromosome 16p13"}, {"pubmed": 24156266, "text": "Results show that the expression and distribution of NMDA receptors subunits GluN1, GluN2A and GluN2B - together with that of postsynaptic protein PSD-95 - are modified in Alzheimer's disease compared to normal aging"}, {"pubmed": 24227730, "text": "The sigma-1 receptor was coisolated with GluN1 receptor subunit but not with the GluN2A subunit."}, {"pubmed": 24372385, "text": "Array comparative genomic hybridization (aCGH) is used to confirm genes for epileptic and other neurodevelopmental disorders, including GRIN2A and proline-rich transmembrane protein (PRRT), both found in rolandic epilepsy."}, {"pubmed": 24739903, "text": "We demonstrate the functional importance of GRIN2A mutations in melanoma and the significance that ionotropic glutamate receptor signaling has in malignant melanoma."}, {"pubmed": 24915238, "text": "The reported association of a single nucleotide polymorphism, GRIN2A_rs4998386, and its interaction with caffeine intake with PD in Sweden, was replicated."}, {"pubmed": 25261450, "text": "Study found GluN receptor subunit-specific changes in mixed subcortical ischemic vascular dementia(SIVD)/Alzheimer's disease(AD) (decreased GluN1) and SIVD (increased GluN2A and 2B), likely reflecting interaction of ischemic neurovascular and AD processes"}, {"pubmed": 25366762, "text": "GRIN2A gene polymorphisms confer susceptibility to heroin addiction."}, {"pubmed": 25412286, "text": "Based on large, well-characterized datasets independent from the original study, our results are not in favor of an interaction between caffeinated coffee consumption and GRIN2A rs4998386 for Parkinson disease risk"}, {"pubmed": 25596506, "text": "Dysarthria and dyspraxia are found in individuals with GRIN2A mutations, often in the setting of epilepsy-aphasia syndromes. The speech phenotype may occur in the absence of a seizure disorder, reinforcing the role for GRIN2A in motor speech function."}, {"pubmed": 25788577, "text": "NMDARs have a dual role during erythropoiesis, supporting survival of polychromatic erythroblasts and contributing to the Ca(2+) homeostasis from the orthochromatic erythroblast stage to circulating red blood cells."}, {"pubmed": 25958346, "text": "GRIN2A (GT)21 may play a significant role in the etiology of schizophrenia among the Chinese Han population of Shaanxi."}, {"pubmed": 26220384, "text": "Findings suggest that mutations in GRIN2A preferentially are involved in genetic variance of pediatric idiopathic generalized epilepsy and do not contribute significantly to either adult focal epilepsies as temporal lobe epilepsy or generalized epilepsies"}, {"pubmed": 26502998, "text": "To determine genetic variability within the N-methyl-D-aspartate receptor 2A sub-unit (GRIN2A) gene promoter and its association with concussion recovery time."}, {"pubmed": 26584860, "text": "Knockdown of PKD1 did not affect NMDAR internalization but prevented the phosphorylation and inhibition of remaining surface NMDARs and NMDAR-mediated synaptic functions."}, {"pubmed": 27199241, "text": "The GRIN2B and GRIN2A Gene Variants Are Associated With Continuous Performance Test Variables in ADHD."}, {"pubmed": 27230353, "text": "genetic association studies in population in China: Data suggest that one SNP in GRIN2A (rs2650429; but not rs6497540 or rs9302415) is associated with lead-induced neurotoxicity; in this case-control study, cases were lead-exposed workers from battery plants. Lead-exposed individuals have lower serum GRIN2A levels compared with controls; lead decreases GRIN2A expression levels in HEK293 cell."}, {"pubmed": 27659111, "text": "This study demonstrates that GRIN2A mutations in melanoma cause heterogenous effects but some may be oncogenic."}, {"pubmed": 27839871, "text": "most rare variants in GluN2A were associated with epilepsy, whereas GluN2B variants were associated with intellectual disability with or without seizures"}, {"pubmed": 27876530, "text": "Two adjacent phenylalanines in the NMDA receptor GluN2A subunit M3 domain interactively regulate alcohol sensitivity and ion channel gating."}, {"pubmed": 28109652, "text": "data indicate that children with epilepsy due to pathogenic GRIN2A mutations present with different clinical phenotypes and a spectrum of seizure types in the context of a pharmacoresistant epilepsy."}, {"pubmed": 28126851, "text": "the gain-of-function M817V mutation causes overactivation of NMDAR and drives neuronal hyperexcitability."}, {"pubmed": 28182669, "text": "a de novo missense mutation in the GRIN2A gene in a patient with childhood focal epilepsy and acquired epileptic aphasia. The mutant decreases NMDAR activation suggesting NMDAR hypofunction may contribute to the epilepsy pathogenesis."}, {"pubmed": 28242877, "text": "Mutations P79R, C231Y, G483R and M705V caused a significant reduction in glutamate and glycine agonist potency, whilst D731N was non-responsive. These mutants, along with E714K, also showed significantly decreased total protein levels and trafficking to the cell surface, whilst C436R was not trafficked at all."}, {"pubmed": 28262924, "text": "2-methoxyestradiol impacts on glycine/serine-mediated metabolic reprogramming in osteosarcoma cells by its interaction with GRIN1/GluN2A receptors."}, {"pubmed": 28320167, "text": "The GRIN2A genotype was not associated with the rate of clinical progression of PD in the placebo group."}, {"pubmed": 28608743, "text": "This review showed that GRIN2A associate with Obsessive-compulsive disorder."}, {"pubmed": 29056244, "text": "The results of this study GRIN2A mutation is a genetic cause in less than 11% patients with Landau-Kleffner syndrome or atypical benign partial epilepsy."}, {"pubmed": 29161964, "text": "Lifetime mood disorder emerged as a more significant factor for suicidal ideation in systemic lupus erythematosus compared with NR2A gene polymorphism main and interaction effects."}, {"pubmed": 29318639, "text": "The findings of this study do not support the hypothesis of an interaction between the GRIN2A-rs4998386 polymorphism and caffeine intake in determining Parkinson disease risk."}, {"pubmed": 29358611, "text": "GRIN2A rare deleterious and loss of function variants are specifically associated with typical and atypical Rolandic epilepsy."}, {"pubmed": 29896722, "text": "GRIN2A mutation is associated with epilepsy-aphasia spectrum disorders but with a relatively low rate."}, {"pubmed": 29958946, "text": "The results of this study provide preliminary evidence relevant to genetic continuity between schizophrenia and schizotypy for effects of the NMDA receptor gene GRIN2A."}, {"pubmed": 30260902, "text": "Three single nucleotide polymorphisms (SNPs) (rs1448258, rs194355, and rs168866) of GRIN2A were genotyped. The distribution of GRIN2A polymorphisms of our participants are shown as follows: rs1448258 CC 516:943, CT 38:75; rs194355 AA 209:381, AG 258:470, GG 78:163; and rs168866 CC 9:17, CT 117:252, TT 425:756. There were no significant discrepancies between cases and controls."}, {"pubmed": 30544257, "text": "The phenotypic spectrum in grin2a mutations ranged from normal or near-normal development with mild epilepsy and speech delay/apraxia to severe developmental and epileptic encephalopathy, often within the epilepsy-aphasia spectrum."}, {"pubmed": 30590034, "text": "These findings reveal the structural mechanisms by which protons allosterically inhibit human GluN1-GluN2A receptor activity."}, {"pubmed": 30604514, "text": "GluN2A N615K reduces Mg2+ blockade and channel conductance, even for receptors in which one GluN2AN615K is co-assembled with one wild-type GluN2A subunit."}, {"pubmed": 31149903, "text": "recent identification of GRIN2A defects in epilepsy-aphasia spectrum represents a first and major break-through in our understanding of the underlying pathophysiological mechanisms[review]"}, {"pubmed": 31272478, "text": "the expression of both GluN2A transcripts in human and primate but not rodent brain tissue is confirmed, and show that they are translated to two corresponding GluN2A proteins present in human brain."}, {"pubmed": 31429998, "text": "De novo missense variants in GRIN2A identified in children with a set of neurological and neuropsychiatric conditiotion alter residues in the M2 re-entrant loop increasing NMDAR charge transfer in addition to varied and complex influences on NMDAR functional properties, which may underlie the patients' phenotypes."}, {"pubmed": 31807283, "text": "his review compares and contrasts the available information describing the clinical and functional consequences of genetic variations in GRIN2A and GRIN2B.[review]"}, {"pubmed": 31847698, "text": "Association between (GT)n Promoter Polymorphism and Recovery from Concussion: A Pilot Study."}, {"pubmed": 32036246, "text": "Generation of an induced pluripotent stem cell line SYSUi-003-A from a child with epilepsy carrying GRIN2A mutation."}, {"pubmed": 32102377, "text": "Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity."}, {"pubmed": 32191258, "text": "Age-Dependent Changes in Synaptic NMDA Receptor Composition in Adult Human Cortical Neurons."}, {"pubmed": 32247039, "text": "Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors."}, {"pubmed": 33025395, "text": "Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study."}, {"pubmed": 33037073, "text": "Leptin modulates pancreatic beta-cell membrane potential through Src kinase-mediated phosphorylation of NMDA receptors."}, {"pubmed": 33043365, "text": "Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function."}, {"pubmed": 33237434, "text": "Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment."}, {"pubmed": 33370585, "text": "Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study."}, {"pubmed": 33969428, "text": "Correlated conformational dynamics of the human GluN1-GluN2A type N-methyl-D-aspartate (NMDA) receptor."}, {"pubmed": 33976221, "text": "Conformational rearrangement of the NMDA receptor amino-terminal domain during activation and allosteric modulation."}, {"pubmed": 34039076, "text": "Differential Clinical Features in Colombian Patients With Rolandic Epilepsy and Suggestion of Unlikely Association With GRIN2A, RBFOX1, or RBFOX3 Gene Variants."}, {"pubmed": 34321660, "text": "Structural basis of ketamine action on human NMDA receptors."}, {"pubmed": 34726335, "text": "N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants."}, {"pubmed": 34830255, "text": "N-Methyl-d-aspartic Acid (NMDA) Receptor Is Involved in the Inhibitory Effect of Ketamine on Human Sperm Functions."}, {"pubmed": 35228668, "text": "Common synaptic phenotypes arising from diverse mutations in the human NMDA receptor subunit GluN2A."}, {"pubmed": 35513389, "text": "SAPAP3 regulates epileptic seizures involving GluN2A in post-synaptic densities."}, {"pubmed": 36309015, "text": "Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs."}, {"pubmed": 36516565, "text": "GRIN2A-related epilepsy and speech disorders: A comprehensive overview with a focus on the role of precision therapeutics."}, {"pubmed": 37000222, "text": "Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening."}, {"pubmed": 37107537, "text": "Children with Early-Onset Psychosis Have Increased Burden of Rare GRIN2A Variants."}, {"pubmed": 37736757, "text": "GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia."}, {"pubmed": 38214768, "text": "Disease-associated nonsense and frame-shift variants resulting in the truncation of the GluN2A or GluN2B C-terminal domain decrease NMDAR surface expression and reduce potentiating effects of neurosteroids."}, {"pubmed": 38307912, "text": "Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders."}, {"pubmed": 38319733, "text": "METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2."}, {"pubmed": 38538865, "text": "De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor."}, {"pubmed": 38731978, "text": "Dual Role of NMDAR Containing NR2A and NR2B Subunits in Alzheimer's Disease."}], "genomic_pos": {"chr": "16", "end": 10182928, "ensemblgene": "ENSG00000183454", "start": 9753404, "strand": -1}, "genomic_pos_hg19": {"chr": "16", "end": 10276611, "start": 9852376, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001964", "qualifier": "involved_in", "term": "startle response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001975", "qualifier": "involved_in", "term": "response to amphetamine"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007215", "pubmed": 8768735, "qualifier": "involved_in", "term": "glutamate receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007268", "pubmed": 7816096, "qualifier": "involved_in", "term": "chemical synaptic transmission"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0007420", "pubmed": 17526495, "qualifier": "involved_in", "term": "brain development"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007611", "pubmed": 7816096, "qualifier": "involved_in", "term": "learning or memory"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007613", "qualifier": "involved_in", "term": "memory"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008542", "qualifier": "involved_in", "term": "visual learning"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009410", "qualifier": "involved_in", "term": "response to xenobiotic stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009611", "qualifier": "involved_in", "term": "response to wounding"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019233", "qualifier": "involved_in", "term": "sensory perception of pain"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019722", "qualifier": "involved_in", "term": "calcium-mediated signaling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0022008", "qualifier": "involved_in", "term": "neurogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030163", "qualifier": "involved_in", "term": "protein catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030431", "qualifier": "involved_in", "term": "sleep"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0033058", "qualifier": "involved_in", "term": "directional locomotion"}, {"evidence": "ISO", "gocategory": "BP", "id": "GO:0035235", "qualifier": "involved_in", "term": "ionotropic glutamate receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035235", "qualifier": "involved_in", "term": "ionotropic glutamate receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035249", "qualifier": "involved_in", "term": "synaptic transmission, glutamatergic"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042177", "qualifier": "involved_in", "term": "negative regulation of protein catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042417", "qualifier": "involved_in", "term": "dopamine metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042428", "qualifier": "involved_in", "term": "serotonin metabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0043065", "qualifier": "involved_in", "term": "positive regulation of apoptotic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045471", "pubmed": 18445116, "qualifier": "involved_in", "term": "response to ethanol"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048167", "qualifier": "involved_in", "term": "regulation of synaptic plasticity"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0048167", "pubmed": 17526495, "qualifier": "involved_in", "term": "regulation of synaptic plasticity"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0048168", "pubmed": 15003177, "qualifier": "involved_in", "term": "regulation of neuronal synaptic plasticity"}, {"evidence": "ISO", "gocategory": "BP", "id": "GO:0051968", "qualifier": "involved_in", "term": "positive regulation of synaptic transmission, glutamatergic"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051968", "qualifier": "involved_in", "term": "positive regulation of synaptic transmission, glutamatergic"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060079", "qualifier": "involved_in", "term": "excitatory postsynaptic potential"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060291", "qualifier": "involved_in", "term": "long-term synaptic potentiation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0097202", "pubmed": 17526495, "qualifier": "involved_in", "term": "activation of cysteine-type endopeptidase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0097553", "pubmed": 26875626, "qualifier": "involved_in", "term": "calcium ion transmembrane import into cytosol"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0097553", "pubmed": 27839871, "qualifier": "involved_in", "term": "calcium ion transmembrane import into cytosol"}, {"evidence": "ISO", "gocategory": "BP", "id": "GO:0098655", "qualifier": "involved_in", "term": "monoatomic cation transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0098655", "qualifier": "involved_in", "term": "monoatomic cation transmembrane transport"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0098976", "pubmed": 17526495, "qualifier": "involved_in", "term": "excitatory chemical synaptic transmission"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1903539", "qualifier": "involved_in", "term": "protein localization to postsynaptic membrane"}, {"evidence": "ISO", "gocategory": "BP", "id": "GO:1904062", "qualifier": "involved_in", "term": "regulation of monoatomic cation transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1904062", "qualifier": "involved_in", "term": "regulation of monoatomic cation transmembrane transport"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:1904646", "pubmed": 21883149, "qualifier": "NOT involved_in", "term": "cellular response to amyloid-beta"}, {"evidence": "ISO", "gocategory": "BP", "id": "GO:2000463", "qualifier": "involved_in", "term": "positive regulation of excitatory postsynaptic potential"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:2000463", "qualifier": "involved_in", "term": "positive regulation of excitatory postsynaptic potential"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [26875626, 27839871], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISO", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0008021", "qualifier": "located_in", "term": "synaptic vesicle"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0009986", "qualifier": "located_in", "term": "cell surface"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0014069", "qualifier": "located_in", "term": "postsynaptic density"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0017146", "qualifier": "part_of", "term": "NMDA selective glutamate receptor complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0017146", "pubmed": [10480938, 26875626], "qualifier": "part_of", "term": "NMDA selective glutamate receptor complex"}, {"evidence": "ISO", "gocategory": "CC", "id": "GO:0017146", "qualifier": "part_of", "term": "NMDA selective glutamate receptor complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0017146", "qualifier": "part_of", "term": "NMDA selective glutamate receptor complex"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0017146", "pubmed": 17526495, "qualifier": "part_of", "term": "NMDA selective glutamate receptor complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0030659", "qualifier": "located_in", "term": "cytoplasmic vesicle membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0042734", "qualifier": "located_in", "term": "presynaptic membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043197", "qualifier": "located_in", "term": "dendritic spine"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0045211", "qualifier": "located_in", "term": "postsynaptic membrane"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0045211", "pubmed": 15317856, "qualifier": "located_in", "term": "postsynaptic membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0097060", "qualifier": "located_in", "term": "synaptic membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0098839", "qualifier": "is_active_in", "term": "postsynaptic density membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0098978", "qualifier": "located_in", "term": "glutamatergic synapse"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0001540", "pubmed": 26719327, "qualifier": "enables", "term": "amyloid-beta binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004972", "qualifier": "enables", "term": "NMDA glutamate receptor activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004972", "qualifier": "enables", "term": "NMDA glutamate receptor activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004972", "pubmed": 17526495, "qualifier": "enables", "term": "NMDA glutamate receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11937501, 17360663, 17997397, 21653829], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0008270", "qualifier": "enables", "term": "zinc ion binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0022849", "pubmed": 26875626, "qualifier": "enables", "term": "glutamate-gated calcium ion channel activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0022849", "pubmed": 27839871, "qualifier": "enables", "term": "glutamate-gated calcium ion channel activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:1904315", "qualifier": "enables", "term": "transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential"}]}, "homologene": {"genes": [[7955, 563297], [8364, 100489006], [9031, 427678], [9544, 100429880], [9598, 454396], [9606, 2903], [9615, 490012], [10090, 14811], [10116, 24409]], "id": 645}, "interpro": [{"desc": "Receptor, ligand binding region", "id": "IPR001828", "short_desc": "ANF_lig-bd_rcpt"}, {"desc": "Periplasmic binding protein-like I", "id": "IPR028082", "short_desc": "Peripla_BP_I"}, {"desc": "Ionotropic glutamate receptor, C-terminal", "id": "IPR001320", "short_desc": "Iontro_rcpt_C"}, {"desc": "Ionotropic glutamate receptor, metazoa", "id": "IPR001508", "short_desc": "Iono_Glu_rcpt_met"}, {"desc": "Solute-binding protein family 3/N-terminal domain of MltF", "id": "IPR001638", "short_desc": "Solute-binding_3/MltF_N"}, {"desc": "Ionotropic glutamate receptor", "id": "IPR015683", "short_desc": "Ionotropic_Glu_rcpt"}, {"desc": "Glutamate [NMDA] receptor, epsilon subunit, C-terminal", "id": "IPR018884", "short_desc": "NMDAR2_C"}, {"desc": "Ionotropic glutamate receptor, L-glutamate and glycine-binding domain", "id": "IPR019594", "short_desc": "Glu/Gly-bd"}], "ipi": ["IPI00029768", "IPI00902706", "IPI01012161"], "map_location": "16p13.2", "name": "glutamate ionotropic receptor NMDA type subunit 2A", "other_names": ["N-methyl D-aspartate receptor subtype 2A", "N-methyl-D-aspartate receptor channel, subunit epsilon-1", "N-methyl-D-aspartate receptor subunit 2A", "glutamate ionotropic receptor NMDA 2A", "glutamate receptor ionotropic, NMDA 2A", "glutamate receptor, ionotropic, N-methyl D-aspartate 2A"], "pantherdb": {"HGNC": "4585", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95820", "ortholog_type": "LDO", "panther_family": "PTHR18966", "taxid": 10090, "uniprot_kb": "P35436"}, {"RGD": "2737", "ortholog_type": "LDO", "panther_family": "PTHR18966", "taxid": 10116, "uniprot_kb": "Q00959"}, {"Ensembl": "ENSGALG00000007278", "ortholog_type": "LDO", "panther_family": "PTHR18966", "taxid": 9031, "uniprot_kb": "F1NAK2"}, {"Ensembl": "ENSDARG00000114867", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 7955, "uniprot_kb": "A0A2R8QLP2"}, {"ZFIN": "ZDB-GENE-070424-223", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 7955, "uniprot_kb": "F1QDE5"}, {"ZFIN": "ZDB-GENE-070424-129", "ortholog_type": "LDO", "panther_family": "PTHR18966", "taxid": 7955, "uniprot_kb": "F6P6I2"}, {"WormBase": "WBGene00003775", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 6239, "uniprot_kb": "G5EEH3"}, {"FlyBase": "FBgn0053513", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 7227, "uniprot_kb": "Q9W581"}, {"TAIR": "2102975", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9M8W7"}, {"TAIR": "2079681", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q8LGN1"}, {"TAIR": "2166006", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9FH75"}, {"TAIR": "2166001", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9LV72"}, {"EnsemblGenome": "AT4G31710", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "O81776"}, {"TAIR": "2181196", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "O04660"}, {"TAIR": "2047251", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9SHV2"}, {"TAIR": "2047256", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9SHV1"}, {"EnsemblGenome": "AT5G11180", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9LFN8"}, {"EnsemblGenome": "AT5G11210", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9LFN5"}, {"TAIR": "2066148", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "O81078"}, {"TAIR": "2066107", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q8LGN0"}, {"TAIR": "2066086", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9C5V5"}, {"TAIR": "2062586", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9SDQ4"}, {"EnsemblGenome": "AT2G32390", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9SW97"}, {"TAIR": "2207165", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q8GXJ4"}, {"TAIR": "2206095", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q9C8E7"}, {"TAIR": "2081805", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q84W41"}, {"EnsemblGenome": "AT2G17260", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q7XJL2"}, {"TAIR": "2122128", "ortholog_type": "O", "panther_family": "PTHR18966", "taxid": 3702, "uniprot_kb": "Q93YT1"}], "uniprot_kb": "Q12879"}, "pathway": {"biocarta": {"id": "nos1pathway", "name": "nitric oxide signaling pathway"}, "kegg": [{"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}, {"id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04020", "name": "Calcium signaling pathway - Homo sapiens (human)"}, {"id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)"}, {"id": "hsa04080", "name": "Neuroactive ligand-receptor interaction - Homo sapiens (human)"}, {"id": "hsa04713", "name": "Circadian entrainment - Homo sapiens (human)"}, {"id": "hsa04720", "name": "Long-term potentiation - Homo sapiens (human)"}, {"id": "hsa04724", "name": "Glutamatergic synapse - Homo sapiens (human)"}, {"id": "hsa04728", "name": "Dopaminergic synapse - Homo sapiens (human)"}, {"id": "hsa05010", "name": "Alzheimer disease - Homo sapiens (human)"}, {"id": "hsa05014", "name": "Amyotrophic lateral sclerosis - Homo sapiens (human)"}, {"id": "hsa05017", "name": "Spinocerebellar ataxia - Homo sapiens (human)"}, {"id": "hsa05020", "name": "Prion disease - Homo sapiens (human)"}, {"id": "hsa05022", "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)"}, {"id": "hsa05030", "name": "Cocaine addiction - Homo sapiens (human)"}, {"id": "hsa05031", "name": "Amphetamine addiction - Homo sapiens (human)"}, {"id": "hsa05033", "name": "Nicotine addiction - Homo sapiens (human)"}, {"id": "hsa05034", "name": "Alcoholism - Homo sapiens (human)"}, {"id": "hsa05322", "name": "Systemic lupus erythematosus - Homo sapiens (human)"}], "pid": {"id": "reelinpathway", "name": "Reelin signaling pathway"}, "reactome": [{"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-438064", "name": "Post NMDA receptor activation events"}, {"id": "R-HSA-438066", "name": "Unblocking of NMDA receptors, glutamate binding and activation"}, {"id": "R-HSA-438066", "name": "Unblocking of NMDA receptors, glutamate binding and activation"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-6794361", "name": "Neurexins and neuroligins"}, {"id": "R-HSA-6794362", "name": "Protein-protein interactions at synapses"}, {"id": "R-HSA-6794362", "name": "Protein-protein interactions at synapses"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8849932", "name": "Synaptic adhesion-like molecules"}, {"id": "R-HSA-8986944", "name": "Transcriptional Regulation by MECP2"}, {"id": "R-HSA-9022699", "name": "MECP2 regulates neuronal receptors and channels"}, {"id": "R-HSA-9609736", "name": "Assembly and cell surface presentation of NMDA receptors"}, {"id": "R-HSA-9609736", "name": "Assembly and cell surface presentation of NMDA receptors"}, {"id": "R-HSA-9617324", "name": "Negative regulation of NMDA receptor-mediated neuronal transmission"}, {"id": "R-HSA-9620244", "name": "Long-term potentiation"}], "smpdb": [{"id": "SMP00392", "name": "Benzocaine Action Pathway"}, {"id": "SMP00393", "name": "Bupivacaine Action Pathway"}, {"id": "SMP00394", "name": "Chloroprocaine Action Pathway"}, {"id": "SMP00395", "name": "Cocaine Action Pathway"}, {"id": "SMP00396", "name": "Dibucaine Action Pathway"}, {"id": "SMP00397", "name": "Levobupivacaine Action Pathway"}, {"id": "SMP00398", "name": "Lidocaine (Local Anaesthetic) Action Pathway"}, {"id": "SMP00399", "name": "Mepivacaine Action Pathway"}, {"id": "SMP00400", "name": "Oxybuprocaine Action Pathway"}, {"id": "SMP00401", "name": "Prilocaine Action Pathway"}, {"id": "SMP00402", "name": "Procaine Action Pathway"}, {"id": "SMP00403", "name": "Proparacaine Action Pathway"}, {"id": "SMP00404", "name": "Ropivacaine Action Pathway"}, {"id": "SMP00405", "name": "Codeine Action Pathway"}, {"id": "SMP00406", "name": "Morphine Action Pathway"}, {"id": "SMP00407", "name": "Heroin Action Pathway"}, {"id": "SMP00408", "name": "Methadone Action Pathway"}, {"id": "SMP00409", "name": "Oxycodone Action Pathway"}, {"id": "SMP00410", "name": "Hydromorphone Action Pathway"}, {"id": "SMP00411", "name": "Hydrocodone Action Pathway"}, {"id": "SMP00412", "name": "Oxymorphone Action Pathway"}, {"id": "SMP00413", "name": "Alfentanil Action Pathway"}, {"id": "SMP00414", "name": "Carfentanil Action Pathway"}, {"id": "SMP00415", "name": "Fentanyl Action Pathway"}, {"id": "SMP00416", "name": "Remifentanil Action Pathway"}, {"id": "SMP00417", "name": "Sufentanil Action Pathway"}, {"id": "SMP00422", "name": "Imipramine Action Pathway"}, {"id": "SMP00423", "name": "Desipramine Action Pathway"}, {"id": "SMP00424", "name": "Citalopram Action Pathway"}, {"id": "SMP00425", "name": "Escitalopram Action Pathway"}, {"id": "SMP00426", "name": "Fluoxetine Action Pathway"}, {"id": "SMP00431", "name": "Nicotine Action Pathway"}, {"id": "SMP00624", "name": "Methadone Metabolism Pathway"}, {"id": "SMP00671", "name": "Tramadol Action Action Pathway"}, {"id": "SMP00672", "name": "Propoxyphene Action Pathway"}, {"id": "SMP00673", "name": "Levorphanol Action Pathway"}, {"id": "SMP00674", "name": "Anileridine Action Pathway"}, {"id": "SMP00675", "name": "Diphenoxylate Action Pathway"}, {"id": "SMP00676", "name": "Dezocine Action Pathway"}, {"id": "SMP00677", "name": "Levomethadyl Acetate Action Action Pathway"}, {"id": "SMP00678", "name": "Methadyl Acetate Action Pathway"}, {"id": "SMP00679", "name": "3-Methylthiofentanyl Action Pathway"}, {"id": "SMP00680", "name": "Dimethylthiambutene Action Pathway"}, {"id": "SMP00681", "name": "Ethylmorphine Action Pathway"}, {"id": "SMP00683", "name": "Levallorphan Action Pathway"}, {"id": "SMP00684", "name": "Buprenorphine Action Pathway"}, {"id": "SMP00685", "name": "Alvimopan Action Pathway"}, {"id": "SMP00686", "name": "Pentazocine Action Pathway"}, {"id": "SMP00687", "name": "Naltrexone Action Pathway"}, {"id": "SMP00688", "name": "Naloxone Action Pathway"}, {"id": "SMP00689", "name": "Dihydromorphine Action Pathway"}, {"id": "SMP00690", "name": "Ketobemidone  Action Pathway"}, {"id": "SMP00691", "name": "Nalbuphine Action Pathway"}], "wikipathways": [{"id": "WP2059", "name": "Alzheimer,s disease"}, {"id": "WP2636", "name": "Common Pathways Underlying Drug Addiction"}, {"id": "WP4008", "name": "NO-cGMP-PKG mediated Neuroprotection"}, {"id": "WP4222", "name": "Phosphodiesterases in neuronal function"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4312", "name": "Rett syndrome causing genes"}, {"id": "WP4539", "name": "Synaptic signaling pathways associated with autism spectrum disorder"}, {"id": "WP4549", "name": "Fragile X Syndrome"}, {"id": "WP4685", "name": "Melanoma"}, {"id": "WP4698", "name": "Vitamin D-sensitive calcium signaling in depression"}, {"id": "WP4875", "name": "Disruption of postsynaptic signaling by CNV"}]}, "pdb": ["3NFL", "5H8F", "5H8H", "5H8N", "5H8Q", "5I2K", "5I2N", "5KCJ", "5KDT", "5TP9", "5TPA", "6IRA", "6IRF", "6IRG", "6IRH", "7EOQ", "7EOR", "7EOS", "7EOT", "7EOU", "7EU7", "8E99"], "pfam": ["PF00060", "PF00497", "PF01094", "PF10565", "PF10613"], "pharmgkb": "PA28979", "pharos": {"target_id": 3891, "tdl": "Tclin"}, "pir": "S47555", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF218407", "relationship": "is"}, {"id": "GNF221679", "relationship": "is"}, {"id": "GNF228129", "relationship": "is"}, {"id": "GNF229365", "relationship": "is"}, {"id": "GNF250467", "relationship": "is"}, {"id": "GNF250468", "relationship": "is"}, {"id": "GNF250469", "relationship": "is"}, {"id": "GNF250470", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF083193", "relationship": "is"}, {"id": "GNF083194", "relationship": "is"}, {"id": "GNF083195", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051092", "relationship": "is"}, {"id": "GNF055859", "relationship": "is"}, {"id": "GNF060549", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062085", "relationship": "is"}, {"id": "GNF062086", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094662", "relationship": "is"}, {"id": "GNF134319", "relationship": "is"}, {"id": "GNF146910", "relationship": "is"}, {"id": "GNF152270", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1", "NG_011812.2"], "protein": ["NP_000824.1", "NP_001127879.1", "NP_001127880.1", "XP_016878661.1", "XP_016878662.1", "XP_047289949.1", "XP_047289950.1", "XP_054236123.1", "XP_054236124.1", "XP_054236125.1", "XP_054236126.1"], "rna": ["NM_000833.5", "NM_001134407.3", "NM_001134408.2", "XM_017023172.2", "XM_017023173.2", "XM_047433993.1", "XM_047433994.1", "XM_054380148.1", "XM_054380149.1", "XM_054380150.1", "XM_054380151.1"], "translation": [{"protein": "XP_054236125.1", "rna": "XM_054380150.1"}, {"protein": "XP_054236126.1", "rna": "XM_054380151.1"}, {"protein": "XP_054236123.1", "rna": "XM_054380148.1"}, {"protein": "XP_016878661.1", "rna": "XM_017023172.2"}, {"protein": "XP_054236124.1", "rna": "XM_054380149.1"}, {"protein": "NP_001127880.1", "rna": "NM_001134408.2"}, {"protein": "XP_047289949.1", "rna": "XM_047433993.1"}, {"protein": "XP_016878662.1", "rna": "XM_017023173.2"}, {"protein": "XP_047289950.1", "rna": "XM_047433994.1"}, {"protein": "NP_001127879.1", "rna": "NM_001134407.3"}, {"protein": "NP_000824.1", "rna": "NM_000833.5"}]}, "reporter": {"HG-U133_Plus_2": ["206534_at", "231384_at", "242286_at"], "HG-U95Av2": "38236_at", "HG-U95B": ["46626_at", "54354_at"], "HTA-2_0": ["TC16000854.hg.1", "TC16001763.hg.1"], "HuEx-1_0": ["3679801", "3679803", "3679805", "3679807", "3679809", "3679812"], "HuGene-1_1": "7999364", "HuGene-2_1": "16823799"}, "summary": "This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014].", "symbol": "GRIN2A", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1415299"}, "unigene": "Hs.411472", "uniprot": {"Swiss-Prot": "Q12879", "TrEMBL": ["Q59EW6", "Q547U9", "A0A890YTL4", "A0A1B0GUT1", "F5GZ52", "A0A1B0GVW1", "A0A6Q8PHM7", "A0A6Q8PGD2", "A0A1B0GU35"]}, "wikipedia": {"url_stub": "GRIN2A"}}